Funders and Partners
Aeras research and development work is funded by key partners worldwide. Funding streams include grants from foundations and governments, investments from industry partners, and co-investments with other organizations, governments and institutions.
Donor support drives innovation by strengthening and advancing the global pipeline of new TB vaccines, accelerating efforts toward ensuring their availability to all who need them. Aeras thanks the following foundations and governmental organizations for their generous support:
Special thanks to the sites, networks and participants in our clinical trials:
Partners in the Fight
The eventual elimination of TB as a public health threat is a global effort that requires global commitment—and collaboration between governments, research organizations, academic institutions, the private sector and advocacy groups. Together we can rally investment in research and development and foster innovative approaches to ending this disease.